Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19
Introduction: The ongoing pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed important challenges for clinicians and health-care systems worldwide.Areas covered: The aim of this manuscript is to provide brief guidance for intensive care unit management of mechanically ventilated patients with COVID-19 based on the literature and our direct experience with this population. PubMed, EBSCO, and the Cochrane Library were searched up until 15th of January 2021 for relevant literature.Expert opinion: Initially, the respiratory management of COVID-19 relied on the general therapeutic principles for acute respiratory distress syndrome; however, recent findings have suggested that the pathophysiology of hypoxemia in patients with COVID-19 presents specific features and changes over time. Several therapies, including antiviral and anti-inflammatory agents, have been proposed recently. The optimal intensive care unit management of patients with COVID-19 remains unclear; therefore, ongoing and future clinical trials are warranted to clarify the optimal strategies to adopt in this cohort of patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Expert review of respiratory medicine - 15(2021), 10 vom: 26. Okt., Seite 1293-1302 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Robba, Chiara [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibiotic therapy |
---|
Anmerkungen: |
Date Completed 23.09.2021 Date Revised 11.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/17476348.2021.1906226 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM322914361 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM322914361 | ||
003 | DE-627 | ||
005 | 20231225183042.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/17476348.2021.1906226 |2 doi | |
028 | 5 | 2 | |a pubmed24n1076.xml |
035 | |a (DE-627)NLM322914361 | ||
035 | |a (NLM)33734900 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Robba, Chiara |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.09.2021 | ||
500 | |a Date Revised 11.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Introduction: The ongoing pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed important challenges for clinicians and health-care systems worldwide.Areas covered: The aim of this manuscript is to provide brief guidance for intensive care unit management of mechanically ventilated patients with COVID-19 based on the literature and our direct experience with this population. PubMed, EBSCO, and the Cochrane Library were searched up until 15th of January 2021 for relevant literature.Expert opinion: Initially, the respiratory management of COVID-19 relied on the general therapeutic principles for acute respiratory distress syndrome; however, recent findings have suggested that the pathophysiology of hypoxemia in patients with COVID-19 presents specific features and changes over time. Several therapies, including antiviral and anti-inflammatory agents, have been proposed recently. The optimal intensive care unit management of patients with COVID-19 remains unclear; therefore, ongoing and future clinical trials are warranted to clarify the optimal strategies to adopt in this cohort of patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Severe acute respiratory syndrome coronavirus-2 | |
650 | 4 | |a antibiotic therapy | |
650 | 4 | |a anticoagulation | |
650 | 4 | |a corticosteroids | |
650 | 4 | |a mechanical ventilation | |
700 | 1 | |a Battaglini, Denise |e verfasserin |4 aut | |
700 | 1 | |a Ball, Lorenzo |e verfasserin |4 aut | |
700 | 1 | |a Pelosi, Paolo |e verfasserin |4 aut | |
700 | 1 | |a Rocco, Patricia R M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Expert review of respiratory medicine |d 2007 |g 15(2021), 10 vom: 26. Okt., Seite 1293-1302 |w (DE-627)NLM190765666 |x 1747-6356 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2021 |g number:10 |g day:26 |g month:10 |g pages:1293-1302 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/17476348.2021.1906226 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2021 |e 10 |b 26 |c 10 |h 1293-1302 |